What is Fluorescence in situ hybridization probe Market Scope?
It is a laboratory technique that is used for detecting a particular or a specific DNA or RNA sequence in the chromosome. The technique depends on exposing chromosomes to a tiny low DNA sequence known as a quest that encompasses a fluorescent module. It is one of the methods for localizing a piece of DNA within a genome that is called the Fluorescence in situ hybridization probe. The fluorescent dye is attached to a purified piece of DNA and then the DNA is incubated with a full set of chromosomes. The DNA is labeled which finds its matching pair in one of the chromosomes and sticks by it. By looking under the microscope the researcher can find the region where the DNA is bound because of the dye which is fluorescently attached to it.
The Fluorescence in situ hybridization probe market study is being classified by Type (RNA and DNA), by Application (Cancer Diagnosis, Genetic Disorders and Others) and major geographies with country level break-up.
The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Research Analyst at AMA predicts that Players from United States will contribute to the maximum growth of Global Fluorescence in situ hybridization probe market throughout the predicted period.
Abbott Laboratories (United States), Abnova Corporation (Taiwan), Agilent Technologies (United States), Biocare Medical, LLC (United States), Biosearch Technologies Inc. (United States), F. Hoffmann-La Roche AG (Switzerland), Genemed Biotechnologies (United States), Life Science Technologies (India), Oxford Gene Technologies (United Kingdom) and PerkinElmer Inc. (United States) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Horizon Diagnostics (United States).
Analyst at AMA have segmented the market study of Global Fluorescence in situ hybridization probe market by Type, Application and Region.
On the basis of geography, the market of Fluorescence in situ hybridization probe has been segmented into .
In January 2019, Oxford Gene Technology announced that it had received the US FDA's “de novo classification” for eight of its “Cytocell Aquarius Hematology Fluorescent In Situ Hybridization Probes (FISH)” that are specifically for acute myeloid Leukemia (AML) and myelodysplastic syndromes (AML) have developed MDS) applications. This leads to greater consumer acceptance of their products as the probes deliver high-quality results in less time. and In April 2018, Agilent Technologies, Inc. announced that it had added several offerings to its In-Situ Hybridization Probes that are compatible with its Dako Omnis product. They also announced that a manual IGFISH panel for use in lymphoma that is already CE-marked for in vitro diagnostics will be available to the European market. Using these probes in combination with Agilent's “Dako Omnis” improves results efficiency and increases the productivity of research laboratories.
Influencing Market Trend
- Growing Adaption of the In-Vitro Diagnosis
- Adoption of Advanced Technologies
- Growing Prevalence of Genetic Disorders
- Increase in the Number of Chronic Disease Occurrence
- Rising Prevalence of Breast Cancer
- Government Initiatives to Support the R & D
- High Cost of the Technique
- Existence of Variations in The Regulations for The Development and Usage of These Probes
- Absence of The Skilled Professionals to Interact and Utilize the Technology
Key Target AudienceNew Entrants/Investors, Analysts and Strategic Business Planners, Providers of Fluorescence in situ hybridization probe, Venture Capitalists and Private Equity Firms and End-Use Industry
Customization available in this Study:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
To compete effectively, companies also require quantitative estimates of the future growth and qualitative nature of the market. AMA Research & Media features not just specific market sizing estimates, but also include significant value-added commentary on Technological Trends and Innovations, Regulatory Policies, Market Maturity Indicators, Market Share Movements, New Entrants into the Market & Entry/Exit Barriers, Consumer Demographics, Supporting Company Financial and Cash Flow Planning, Open Up New Markets , To Seize Powerful Market Opportunities, Key Decision in Planning and to Further Expand Market Share, Identify Key Business Segments, Market Proposition & Gap Analysis.